Key Points Immuron submits Investigational new drug (IND) application to FDA for clinical development of IMM-529 as product ...

Some of the key facts of the Clostridium Difficile Infections Market Report: ...

Immuron (IMRN) announced that it has submitted an Investigational New Drug, or IND, application to the FDA for clinical development of IMM-529.

Confused about prebiotics vs. probiotics? Here, the key differences, health benefits, and how to choose the right one to ...

Lumen is led by CEO Brian Finrow, a former senior vice president at Adaptive Biotechnologies, and Chief Science Officer Jim Roberts, the former head of basic sciences at the Fred Hutchinson Cancer ...

Joe Flacco will start for the Cincinnati Bengals on Sunday at Green Bay after the veteran quarterback was acquired from the ...

Real Madrid defensive mainstay Eder Militao considered retiring from football, he revealed during a press conference while ...

With Arsenal now top of the Premier League at the international break and with some fine displays so far, that belief is growing, and that is reflected by former star Ian Wright. Speaking on The ...

Delhi Minister Kapil Mishra attended the FICCI Frames Silver Jubilee Edition on Wednesday, where he interacted with several well-known film personalities, including Anil Kapoor, Divya Dutta, Pratik ...

Several months ago, my right eye began to be bothered by “little critters” flying through the air; when I tried to brush them away, nothing existed. I mentioned ...

Lumen Bioscience—a clinical-stage biotech developing orally delivered biologics—today announced key leadership enhancements.